Lumos Labs

Written By hm

In this episode, Dr. Bob Schafer, CEO of Lumos Labs, discusses the company's evolution from the popular brain training platform, Lumosity, to a leader in the development of digital therapeutics for the brain. Lumos Labs is pioneering the use of science-backed gameplay to tackle cognitive issues associated with conditions like ADHD.

We discuss:

  • The unique dataset behind Lumosity, with over 100 million users and 8 billion gameplays

  • How their extensive research fueled the shift towards digital therapeutics

  • Challenges faced by early digital therapeutic companies, and the need for adaptable business models

  • Lumos Labs' approach to commercialization and ensuring accessibility

  • The future of digital health and medicine in addressing brain health and cognitive function

Meet the CEO

Dr. Bob Schafer joined Lumos Labs in 2015 in the acquihire of Prophecy Sciences, a neuroscience startup he founded in 2012. He has led Lumosity DTx, the company’s medical products division, as its President since its inception in 2021, and has also served as Chief Science Officer of Lumos Labs since 2019. Bob holds a PhD in Neuroscience from Stanford University, and did postdoctoral research at MIT.

hm
Previous

Scene Health
Next

Building Your Startup Board